ERBB2 and triple-negative breast carcinoma: The results showed that in patients with HER2 and LUMINAL subtypes, the low-risk group had a better prognosis than the high-risk group (Figure 6H, 6I), while the prognosis of patients with triple-negative breast cancer (TNBC) was not (Figure 6G).